Agents and Actions

, Volume 17, Issue 1, pp 14–20 | Cite as

The effects of diosmin (a benzo-pyrone) upon some high-protein oedemas: Lung contusion, and burn and lymphoedema of rat legs

  • J. R. Casley-Smith
  • Judith R. Casley-Smith
Histamine and Kinins


Oral diosmin (a benzo-pyrone) was used to treat rats with contused lungs, in doses of 50 or 200 mg/kg/day. The contusion was produced by direct trauma. The lungs were examined with the electron microscope, both qualitatively and quantitatively, at 1, 2 and 4 days. It was found that diosmin considerably reduced interstitial oedema and tissue disorganization. The concentration of protein, both in the interstitial tissue and in the air spaces, was also much reduced. There was a greater effect at the higher dosage than at the lower one. In two other experiments, this drug was used in the usual models of burn oedema of the rat foot and acute lymphoedema of the rat leg-estimating the amount of oedema by weighing the parts. A low dose (50 mg/kg) reduced the burn oedema; a high dose (200 mg/kg) did not. Both doses reduced the acute lymphoedema of the whole leg, or thigh. The high dose did not do this in the foot, but the low one did. At high doses, diosmin has the usual benzo-pyrone property of releasing mediators in the rat-foot. In other tissues (and, no doubt, species) this drug reduces many forms of high-protein oedema, like the other benzo-pyrones.


Electron Microscope Usual Model Interstitial Oedema Interstitial Tissue Direct Trauma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    S.O. Bohman,Effects on tissue fine structure of variations in colloidal osmotic pressure of glutaraldehyde fixatives, J. Ultrastruct. Res.30, 195–208 (1970).CrossRefPubMedGoogle Scholar
  2. [2]
    R. Brignoli, L. Busch, J. Heusser andW. Keller, New data on the experimental pharmacology and pharmacokinetics of synthetic diosmin. InInt. Symp. Venous Diseases of the Lower Limbs, Florence. Academic Press, New York and London in press 1985.Google Scholar
  3. [3]
    J.R. Casley-Smith,The actions of the benzopyrones on the blood-tissue-lymph system, Folia angiol.24, 7–22 (1976).Google Scholar
  4. [4]
    J.R. Casley-Smith,The concentrating of proteins in the initial lymphatics and their rediluting in the collecting lymphatics, Folia angiol.25, 81–89 (1977).Google Scholar
  5. [5]
    J.R. Casley-Smith,Human trials of the benzopyrones in high-protein oedemas, Folia angiol.30/31, 313–327 (1982).Google Scholar
  6. [6]
    J.R. Casley-Smith andJudith, R. Casley-Smith,High-protein Oedemas and the Benzo-pyrones, Lippincott, Sydney, in press, 1985.Google Scholar
  7. [7]
    J.R. Casley-Smith andK.W.J. Crocker,Estimation of section thickness, etc. by quantitative electron microscopy, J. Microscopy103, 351–368 (1975).Google Scholar
  8. [8]
    J.R. Casley-Smith andR.M. Gaffney,Excess plasma proteins as a cause of chronic inflammation and lymphoedema. Qualitative electron microscopy, J. Path.133, 243–272 (1981).CrossRefPubMedGoogle Scholar
  9. [9]
    J.R. Casley-Smith, P. Eckert andE. Földi-Börcsöck,The fine structure of pulmonary contusion and the effect of various drugs, Br. J. exp. Path.57, 487–496 (1976).Google Scholar
  10. [10]
    J.R. Casley-Smith, P. Eckert, E. Földi-Börcsök andM. Földi,The effect of macrophage poisoning by silica on experimental pulmonary contusion and its benzo-pyrone treatment, Br. J. Exp. Path.58, 386–390 (1977).Google Scholar
  11. [11]
    P. Desnoyers, J. Virgitti, F. Rodier andM. Clener,Activité vitaminique P et C 2 d'un hétéroside flavonique. La diosmine, Thérapie23, 1333–1342 (1968).Google Scholar
  12. [12]
    P. Eckert, H. Frommhold, M. Doehn andK. Riesner,Morphologie und Röntgenbild der Rattenlunge bei der experimentallen Lungenkontusion, Langenbeck's Arch. Sur, Suppl. Forum, 357–359 (1975).Google Scholar
  13. [13]
    G. Feuer,The metabolism and biological actions of coumarin, Prog. Med. Chem.10, 85–168 (1974).PubMedGoogle Scholar
  14. [14]
    M. Földi andJ.R. Casley-Smith,The roles of the lymphatics and the cells in high-protein oedemas, Mol. Aspects Med.2, 77–146 (1978).CrossRefGoogle Scholar
  15. [15]
    M. Gabór, Anti-inflammatory substances of plant origin. InAnti-Inflammatory Drugs, pp. 698–724 (Ed.J.R. Vane andS.H. Ferreira) Springer, Berlin, Heidelberg and New York 1979.Google Scholar
  16. [16]
    G. Hopf, H.J. Kaessmann, I. Pekker, E.A. Schäfer andH.G. Weber,Experimentelle Untersuchungen der Beeinflussung des postoperativen Extremitätenödems am Hunde mit einem Cumarin-Präparar, Arzneimittel-Forsch.21, 854–855 (1971).Google Scholar
  17. [17]
    G. Lazar, E. Husztik, I. Szilagyi, G. Blazso andM. Gabor, New data on the biogenic amine liberator effect ofO-(β-Hydroxyethyl)-rutoside. InFlavonoids and Bioflavonoids, Current Research Trends, pp. 381–386 (Ed.L. Farkas, M. Gabor andK. Kallay) Elsevier, Amsterdam, Oxford, New York (1977).Google Scholar
  18. [18]
    J. Lecomte,Pouvir amino-libérateur des bioflavonoides chez le rat, C.R. Séanc. Soc. Biol.165, 433–435 (1971).Google Scholar
  19. [19]
    S.H. Miller, M. Abell, D. Buck, D. Kress, T.S. Davis andJ. DeMuth,Effects of 5,6-Benzo-alphapyrone on traumatic edema due to crush and burn injury, J. Trauma21, 372–375 (1981).PubMedGoogle Scholar
  20. [20]
    G. Millonig,Advantage of a phosphate buffer for OsO 4 solutions in fixation, J. appl. Phys.32, 1637–1642 (1961).Google Scholar
  21. [21]
    N.B. Piller,Benzo-pyrones: their selective injury to rabbit vascular endothelium, Clin. & exp. Pharmacol. & Physiol.3, 127–139 (1976).Google Scholar
  22. [22]
    N.B. Piller andL. Clodius, Clinical results of the effectiveness of Venalot in 103 postmastectomy lymphoedema patients. InProc. VII Cong. Int. Soc. Lymphology, Montreal, 1981, pp. 475–479 (Ed.V. Bartos) Avicenum, Prague 1982Google Scholar
  23. [23]
    S.F. Ryan, A. Ciannella andD. Dumais,The structure of the interalveolar septum of the mammalian lung, Anat. Rec.165, 467–475 (1969).CrossRefPubMedGoogle Scholar
  24. [24]
    G. Uhlig,Antiphlogististische Wirksamkeit verschiedener Pharmaka, Z. allg. Med.57, 44–48 (1981a).Google Scholar
  25. [25]
    G. Uhlig,Schwellungsprophylaxe nach exogenem Trauma, Z. allg. Med.57, 127–131 (1981b).Google Scholar
  26. [26]
    E.R. Weibel,Morphological basis of alveolarcapillary gas exchange, Physiol. Rev.53, 419–495 (1973).PubMedGoogle Scholar
  27. [27]
    W.H.O.,Sixth Report on the World Health Situation, 1973–1977, I: Global Analysis, W.H.O., Geneva 1980.Google Scholar
  28. [28]
    D.A. Willoughby andM. DiRosa, A unifying concept for inflammation: a new appraisal of some old mediators. InImmunopathology of Inflammation, pp. 28–38. Excerpta Medica Int. Cong. Series No. 229 1970.Google Scholar

Copyright information

© Birkhäuser Verlag 1985

Authors and Affiliations

  • J. R. Casley-Smith
    • 1
  • Judith R. Casley-Smith
    • 1
  1. 1.The Henry Thomas Laboratory (Microcirculatory Research)University of AdelaideAdelaideAustralia

Personalised recommendations